Brokerages Set Albemarle Co. (NYSE:ALB) Target Price at $122.60

Shares of Albemarle Co. (NYSE:ALBGet Free Report) have been given a consensus rating of “Hold” by the twenty-three research firms that are covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, fifteen have given a hold recommendation and seven have issued a buy recommendation on the company. The average 1-year price target among brokerages that have issued ratings on the stock in the last year is $122.60.

ALB has been the topic of several recent analyst reports. JPMorgan Chase & Co. dropped their target price on shares of Albemarle from $115.00 to $78.00 and set a “neutral” rating on the stock in a report on Monday, August 19th. Scotiabank decreased their target price on Albemarle from $135.00 to $85.00 and set a “sector perform” rating for the company in a research note on Tuesday, August 6th. UBS Group dropped their price target on Albemarle from $124.00 to $109.00 and set a “neutral” rating on the stock in a research report on Tuesday, July 9th. Bank of America reduced their price objective on Albemarle from $135.00 to $126.00 and set a “buy” rating for the company in a research report on Friday, August 2nd. Finally, Wells Fargo & Company downgraded shares of Albemarle from an “overweight” rating to an “equal weight” rating and lowered their price objective for the stock from $145.00 to $100.00 in a research note on Thursday, July 11th.

Read Our Latest Analysis on Albemarle

Institutional Investors Weigh In On Albemarle

Several large investors have recently made changes to their positions in ALB. WFA Asset Management Corp bought a new position in Albemarle during the 1st quarter valued at about $25,000. First Community Trust NA bought a new position in shares of Albemarle in the second quarter valued at approximately $25,000. CVA Family Office LLC raised its stake in shares of Albemarle by 610.0% in the second quarter. CVA Family Office LLC now owns 284 shares of the specialty chemicals company’s stock valued at $27,000 after acquiring an additional 244 shares during the last quarter. USCF Advisers LLC boosted its holdings in shares of Albemarle by 100.0% in the 4th quarter. USCF Advisers LLC now owns 200 shares of the specialty chemicals company’s stock worth $29,000 after acquiring an additional 100 shares in the last quarter. Finally, Jones Financial Companies Lllp grew its position in Albemarle by 2,942.9% during the 4th quarter. Jones Financial Companies Lllp now owns 213 shares of the specialty chemicals company’s stock worth $31,000 after acquiring an additional 206 shares during the last quarter. Institutional investors own 92.87% of the company’s stock.

Albemarle Stock Up 4.2 %

Albemarle stock opened at $90.50 on Thursday. The company has a current ratio of 2.67, a quick ratio of 1.91 and a debt-to-equity ratio of 0.38. Albemarle has a 1-year low of $71.97 and a 1-year high of $203.62. The firm’s fifty day simple moving average is $91.20 and its 200-day simple moving average is $111.64. The company has a market capitalization of $10.64 billion, a P/E ratio of 32.91, a P/E/G ratio of 3.48 and a beta of 1.57.

Albemarle (NYSE:ALBGet Free Report) last posted its earnings results on Wednesday, July 31st. The specialty chemicals company reported $0.04 earnings per share for the quarter, missing the consensus estimate of $0.53 by ($0.49). The company had revenue of $1.43 billion for the quarter, compared to the consensus estimate of $1.34 billion. Albemarle had a negative net margin of 6.72% and a positive return on equity of 6.38%. Albemarle’s quarterly revenue was down 39.7% on a year-over-year basis. During the same quarter last year, the business earned $7.33 earnings per share. Sell-side analysts forecast that Albemarle will post 1.67 earnings per share for the current fiscal year.

Albemarle Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 1st. Shareholders of record on Friday, September 13th will be issued a dividend of $0.405 per share. The ex-dividend date is Friday, September 13th. This is a boost from Albemarle’s previous quarterly dividend of $0.40. This represents a $1.62 dividend on an annualized basis and a dividend yield of 1.79%. Albemarle’s dividend payout ratio (DPR) is presently 58.91%.

About Albemarle

(Get Free Report

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.

See Also

Analyst Recommendations for Albemarle (NYSE:ALB)

Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.